BML (BMLKF) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 09, 2026)


BMLKF BML Inc BMLKF
81 GF Score
Price $25.21
GF Value $26.53
! 2 Warning Signs
View Full Analysis

What is BML 5-Year Yield-on-Cost %?

BML BMLKF 81 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus rates BMLKF with a GF Score™ of 81/100 and a GF Value™ of $26.53. The stock has 2 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, BML ranks better than 73.85% on this metric.

BML's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for BML's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, BML's highest Yield on Cost was 6.33. The lowest was 0.00. And the median was 2.63.


BMLKF's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.34
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

BML  (OTCPK:BMLKF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


BML 5-Year Yield-on-Cost % Related Terms


BMLKF vs TMO, DHR, IDXX: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, BML's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where BML's 5-Year Yield-on-Cost % falls into.


BMLKF
81GF Score
BML Inc BMLKF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BML 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of BML is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
BML (BMLKF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on BML and its competitors. According to the industry distribution chart, BML ranks #17 out of 65 companies in the Medical Diagnostics & Research industry, placing it in the top 26.2%.
Is BML's 5-Year Yield-on-Cost % too high?
BML's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, BML ranks #17 out of 65 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, BML has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does BML's 5-Year Yield-on-Cost % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, BML ranks #17 out of 65 companies for 5-Year Yield-on-Cost %. This puts BML in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.34, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on BML and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BML's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $26.53, compared to a current price of $25.21 — trading 5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. BML's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For BML (BMLKF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (BMLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of $25.21 is trading 5% below its estimated GF Value™ of $26.53.

Key valuation signals for BMLKF:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $26.53 vs. price of $25.21 (5% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BML Business Description

Other Exchanges 4694:Japan
Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
81GF Score

Get the complete analysis for BMLKF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.21
Price
$26.53
GF Value